Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: anti-infectives - Genelabs Technologies

Next Previous
X
Search
Drug Profile

Research programme: anti-infectives - Genelabs Technologies

Alternative Names: Anti-infectives research programme - Genelabs; DNA-binding polyheterocyclic compounds - Genelabs; GL 047374; GL 118172; GL 243287; GL 359986; GL 478057; GL 48087; GL 521997; GL 548043; GL 568816; GL 579225; GL 663142; GL 700241; GL 701649; GL 703027; GL 832293; GL 886217; GL 898298; Pyrrole tetraamides research programme - Genelabs

Latest Information Update: 04 Mar 2008

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Genelabs Technologies
  • Class Amides; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Bacterial infections; Mycoses

Most Recent Events

  • 18 Nov 2004 Discontinued - Preclinical for Bacterial infections in USA (unspecified route)
  • 14 Jun 2002 Preclinical trials in Mycoses in USA (unspecified route)
  • 07 Mar 2002 Early research in Bacterial infections in USA (unspecified route)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top